The rapid implementation of SARS-CoV-2 vaccination is now a global health-care priority.
Successful phase 3 trial outcomes have been reported for numerous vaccines that induce …

Objective There is an urgent need to assess the impact of immunosuppressive therapies on
the immunogenicity and efficacy of SARS-CoV-2 vaccination. Methods Serological and T-…

Background The importance of human leukocyte antigen (HLA) matching in renal transplantation
is well recognized, with HLA-DR compatibility having the greatest influence. De novo …

Background Strategies to minimize the risk of transmission and acquisition of COVID-19
infection in patients with ESKD receiving in-center hemodialysis have been rapidly implemented …

The effects of the coronavirus disease-2019 (COVID-19) pandemic, particularly among those
with chronic kidney disease (CKD), who commonly have defects in humoral and cellular …

We sought to compare neutralising antibody responses between seronaive haemodialysis
patients and the healthy individuals we have already reported on as part of the Legacy study. …

Data are shown as median with IQR. Statistical analysis is by MannWhitney test (A) or
KruskallWallis test with Dunns posthoc correction (B).(A) Kidney transplant recipients who …

Patients with end stage kidney disease receiving in-center hemodialysis (ICHD) have had
high rates of SARS-CoV-2 infection. Following infection, patients receiving ICHD frequently …

Establishing the equipoise between infection and rejection in any individual transplant
recipient has always been the aim when prescribing immunosuppression. Today the world is …

IgA nephropathy (IgAN) is a common cause of chronic kidney disease and end-stage renal
failure, especially in young people. Due to a wide range of clinical outcomes and difficulty in …